ChemoMetec A/S(GB:0DZ0)
kr 709.00-19.25 (-2.64%)
GB:0DZ0
ChemoMetec A/S financials statements
kr 709.00
At close:-19.25 (-2.64%)
ChemoMetec A/S (0DZ0) Financial Statements
1 Followers
ChemoMetec A/S Financial Overview
ChemoMetec A/S's market cap is currently kr12.64B. The company's EPS TTM is kr11.60; its P/E ratio is 61.08; ChemoMetec A/S is estimated to report earnings on February 3, 2027, and the estimated EPS forecast is kr4.87. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 511.06M | kr 495.57M | kr 407.87M | kr 444.40M | kr 428.39M |
| Gross Profit | kr 485.99M | kr 465.51M | kr 367.60M | kr 395.39M | kr 384.25M |
| Operating Income | kr 251.00M | kr 247.68M | kr 178.78M | kr 228.51M | kr 201.53M |
| EBITDA | kr 281.25M | kr 258.05M | kr 193.98M | kr 251.84M | kr 224.74M |
| Net Income | kr 201.84M | kr 186.41M | kr 136.28M | kr 178.67M | kr 159.47M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 293.56M | kr 341.85M | kr 296.15M | kr 316.57M | kr 209.03M |
| Total Assets | kr 860.90M | kr 828.05M | kr 676.67M | kr 657.98M | kr 501.27M |
| Total Debt | kr 4.59M | kr 6.40M | kr 4.16M | kr 7.16M | kr 6.79M |
| Net Debt | kr -285.58M | kr -335.44M | kr -291.99M | kr -309.41M | kr -202.23M |
| Total Liabilities | kr 135.50M | kr 154.69M | kr 111.36M | kr 124.93M | kr 144.07M |
| Stockholders' Equity | kr 725.39M | kr 673.36M | kr 565.32M | kr 533.04M | kr 357.20M |
| Cash Flow | |||||
| Free Cash Flow | kr 182.04M | kr 177.58M | kr 85.47M | kr 113.33M | kr 120.94M |
| Operating Cash Flow | kr 210.36M | kr 207.45M | kr 129.00M | kr 154.15M | kr 176.86M |
| Investing Cash Flow | kr -99.79M | kr -85.52M | kr -43.49M | kr -40.83M | kr -56.05M |
| Financing Cash Flow | kr -161.58M | kr -74.96M | kr -105.72M | kr -2.92M | kr -69.01M |
Currency in DKK
